Genetics of Myeloproliferative Neoplasms
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference70 articles.
1. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.;Rowley;Nature,1973
2. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.;Kantarjian;N Engl J Med,2002
3. Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients.;Peng;J Clin Oncol,2004
4. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.;Talpaz;Blood,2002
5. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.;Baxter;Lancet,2005
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analysis of Plasma microRNA Profiles in Essential Thrombocythemia Using a Novel Multi-Gene Detection Platform;INT J GERONTOL;2023
2. A JAK tyrosine kinase and pseudokinase Co-inhibition strategy combines enhanced potency and on-demand activation;European Journal of Medicinal Chemistry;2023-03
3. Review: JAK2V617F Allele Burden in Diagnosis and Therapeutic Monitoring of Myeloproliferative Neoplasms;European Journal of Medical and Health Sciences;2023-02-18
4. Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology;Diagnostics;2023-01-03
5. The Contribution of JAK2 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms;International Journal of Molecular Sciences;2022-10-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3